1.Parsian S,
Rahbar H,
Allison KH.
Non-malignant Breast lesions: ADCs of Benign and High-Risk Subtypes Assessed as False-Positive at Dynamic Enhanced MR Imaging Radiology: Volume 265: Number 3—Dec.
2012:696-706
2.Chen X,
Li W,
Zhang Y,
Meta-analysis of quantitative diffusion-weighted MR imaging in the differential diagnosis of breast lesions BMC Cancer 2010,
10:693
3.Koh DM,
Collins DJ.
Diffusion-weighted MRI in the body: applications and challenges in oncology.
AJR Am J Roentgenol 2007;188(6):1622–1635.
4..Partridge S,
Amornsiripanitch N.
DWI in the Assessment of Breast Lesions Topics in Magnetic Resonance Imaging October 2017 Volume 26,
Number 5,201- 209
5.Zhang L,
Tang M,
Min Z.
Accuracy of combined dynamic contrast- enhanced magnetic resonance imaging and diffusion-weighted imaging for breast cancer detection: a meta-analysis.
Acta Radiol.
2016;57: 651 – 660.
6.Arponent O,
Sudah M,
Masarwah A.
Diffusion-Weighted Imaging in 3.0 Tesla Breast MRI: Diagnostic Performance and Tumor Characterization Using Small Subregions vs.
Whole Tumor Regions of Interest PLOS ONE 2015,
10(10): e0138702.
doi:10.1371/
7.Kul S,
Cansu A,
Alhan E et al.
Contribution of diffusion-weighted imaging to dynamic contrast-enhanced MRI in the characterization of breast tumors.
Am J Roentgenol 2011;196:210–217.
8.Yoo H,
Shin HJ,
Baek S et al.
Diagnostic performance of apparent diffusion coefficient and quantitative kinetic parameters for predicting additional malignancy in patients with newly diagnosed breast cancer.
Magn Reson Imaging 2014;32:867– 874.
9.Tan SL,
Rahmat K,
Rozalli FI et al.
Differentiation between benign and malignant breast lesions using quantitative diffusion-weighted sequence on 3 T MRI.
Clin Radiol 2014; 69: 63–71.
10.Moukhtar FZ,
Maati El AAA.
Apparent diffusion coefficient values as an adjunct to dynamic contrast enhanced MRI for discriminating benign and malignant breast lesions presenting as mass and non-mass like enhancement.
Egyptian Journal of Radiology and Nuclear Medicine 2014;45:597–604.